Unlock New Possibilities with PsychoGenics’ Special Offer!
We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion! Offer Details: About SmartCube® and eCube® : SmartCube is...
PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development
PsychoGenics Inc. announced the appointment of Stephen Morairty, Ph.D., as Vice President of Translational Neuroscience and Jean-Sebastien Valois, MSc, as...
PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities
Biopharmaceutical Industry Veterans David Bleakman and Thomas Oakley Each Bring Three Decades of Experience to the Company Paramus, N.J., June...
PsychoGenics and Collaborations Pharmaceuticals Awarded a $1M grant to Use AI Platforms to Design New Drugs for Mental Health Disorders
September 5, 2023, Paramus, New Jersey – PsychoGenics Inc. (PsychoGenics) and Collaborations Pharmaceuticals, Inc. (CPI) are pleased to announce that...
Preclinical Pain Models
PsychoGenics is a leading authority in preclinical research for pain disorders, dedicated to advancing the development of effective therapies to...
Unlock New Possibilities with PsychoGenics’ Special Offer!
We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion, available throughout the year. Offer Details:...
Unlock New Possibilities with PsychoGenics’ Special Offer!
We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion! Offer Details: About SmartCube® and eCube®...
Preclinical Microbiome Research
Leveraging our extensive experience working with rodent disease models, PsychoGenics offers a comprehensive suite of services that can help explore...
Preclinical Behavioral and In Vivo Testing Studies
PsychoGenics is a one-stop shop for CNS discovery services, with expertise in a broad range of capabilities from EEG to...
Our Research
Combine our expertise with yours to spark the translational power of your next CNS breakthrough. Therapeutic Areas